The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for FFF Enterprises sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
FFF Enterprises Inc (FFF) is a supplier of critical-care biopharmaceuticals and plasma products. The company’s products include biosurgical products, surgical sealants, coagulation products, albumin and plasma protien fractions, immune globulins, hyperimmune globulins, anti thrombin products, biopharmaceutical products, pharmaceutical products, specialty products, oncology products, ancillary products, and influenza vaccines, among others. It also offers diluent sterile, diphtheria tetanus, polio virus vaccines, novartis vaccines, high dose and fluzone intradermals, and fluarix quadrivalents, among others. FFF provides services such as verified inventory programs, inventory management, recall system solutions, and customer care services. The company caters to critical-care biopharmaceuticals, biotechnology, and pharmaceutical companies. It operates in Temecula and Kernersville, the US. FFF is headquartered in Temecula, California, the US. Key subsidiaries of FFF Enterprises include NuFACTOR and VaxAmerica.
The key metrics of FFF Enterprises related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As FFF Enterprises is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as FFF Enterprises.
For a detailed understanding of the performance of FFF Enterprises, buy the report here.